Retraction|Volume 16, Issue 9|pp 8399 Retraction for: Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma
Quan Liu1Department of Plastic Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan, China, Wei Cui1Department of Plastic Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan, China, Chao Yang2Department of Traditional Chinese Medicine Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan, China, Li-Ping Du1Department of Plastic Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan, China
- 1Department of Plastic Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan, China
- 2Department of Traditional Chinese Medicine Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan, China
* Equal contribution
Received: December 23, 2023Accepted: April 9, 2024
Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been retracted: Aging has completed its investigation of this paper. We found that four images in Figure 5F, 5G, which present the results of comet assays in A375 (5F) and SK-MEL-28 (5G) cells treated with control mimic or miR-138-5p mimic, or co-treated with miR-138-5p mimic and pcDNA3.1-SIRT7, were also used in Figure 3A, 3B, where cells were treated with circZNF609 shRNA or control shRNA. The same images were used again in Figure 4G, 4H, which show the results of comet assays in A375 and SK-MEL-28 cells treated with control shRNA or circZNF609 shRNA, or co-treated with circZNF609 shRNA and miR-138-5p inhibitor. The authors informed the journal that a portion of the original data is missing, so it is impossible to correct the misused images. All of the authors agreed to retract the manuscript and signed the retraction agreement letter.
